Antibiotic-associated diana, intelligent Clostridium difficiary

Abstract Objective: To study antibiotic-associated diarrhea due to Clostridium difficile. Materials and methods: a retrospective and prospective analysis of literature and studies on C. difficile antibiotic-associated diarrhea was conducted. Results Despite the concerted efforts to improve...

Full description

Saved in:
Bibliographic Details
Main Authors: V. D. Moskaliuk, I. V. Rudan, I. V. Balaniuk, O. V. Myronyk, M. O. Andrushchak
Format: Article
Language:English
Published: Zaporizhzhia State Medical and Pharmaceutical University 2018-10-01
Series:Zaporožskij Medicinskij Žurnal
Subjects:
Online Access:http://zmj.zsmu.edu.ua/article/view/141730/141124
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849397854376820736
author V. D. Moskaliuk
I. V. Rudan
I. V. Balaniuk
O. V. Myronyk
M. O. Andrushchak
author_facet V. D. Moskaliuk
I. V. Rudan
I. V. Balaniuk
O. V. Myronyk
M. O. Andrushchak
author_sort V. D. Moskaliuk
collection DOAJ
description Abstract Objective: To study antibiotic-associated diarrhea due to Clostridium difficile. Materials and methods: a retrospective and prospective analysis of literature and studies on C. difficile antibiotic-associated diarrhea was conducted. Results Despite the concerted efforts to improve the prevention and treatment of C. difficile infection, this infection remains common and serious both in hospitals and among the population. In recent years, germ cell transplantation has emerged as a safe and effective strategy for treating relapsing infections. With further improvement, the microbial transplantation of feces is likely to become the standard of care for periodic infections. Despite the fact that antibiotic therapy and decontamination in health facilities remain important for infection control, effective probiotics and vaccination are likely to become important tools for preventing infection C. difficile in the future. By this time, C. difficile infection continues to be a common and very painful consequence of the use of antibiotics. Pathogenic C. difficile strains form two protein exotoxins, toxin A and toxin B, which cause damage to the intestinal mucosa and inflammation. The infection can be asymptomatic, cause mild diarrhea or cause severe pseudomembranous colitis. The first step is to stop the use of an antibiotic that causes diarrhea. If diarrhea and colitis are serious or persistent, then the drugs of choice are metronidazole and vancomycin. Clostridium difficile is an anaerobic gram-positive, spore-forming, toxin-producing bacilli that is transmitted to humans through the fecal-oral transmission mechanism. In the United States, C. difficile is the most frequently reported nosocomial pathogen in 2011, with 453,000 cases of C. difficile infection and 29,000 deaths associated with C. Difficile infection. Conclusions. To date, the incidence of C. difficle-infections has increased, due to the wide and often uncontrolled use of antibiotics. It should be noted that antibiotic-associated diarrheas due to C. difficile occupy one of the first places in the structure of morbidity and mortality among infectious diarrheas, representing a serious and antimicrobial problem of therapy in the conditions of the in-patient and among the population. CDI has become an increasingly common infection and has shown an increase in severity over the past few years.
format Article
id doaj-art-a71b6f19e51e49fea28169c5295dec69
institution Kabale University
issn 2306-4145
2310-1210
language English
publishDate 2018-10-01
publisher Zaporizhzhia State Medical and Pharmaceutical University
record_format Article
series Zaporožskij Medicinskij Žurnal
spelling doaj-art-a71b6f19e51e49fea28169c5295dec692025-08-20T03:38:49ZengZaporizhzhia State Medical and Pharmaceutical UniversityZaporožskij Medicinskij Žurnal2306-41452310-12102018-10-01572973310.14739/2310-1210.2018.5.141730Antibiotic-associated diana, intelligent Clostridium difficiaryV. D. MoskaliukI. V. Rudan I. V. BalaniukO. V. MyronykM. O. AndrushchakAbstract Objective: To study antibiotic-associated diarrhea due to Clostridium difficile. Materials and methods: a retrospective and prospective analysis of literature and studies on C. difficile antibiotic-associated diarrhea was conducted. Results Despite the concerted efforts to improve the prevention and treatment of C. difficile infection, this infection remains common and serious both in hospitals and among the population. In recent years, germ cell transplantation has emerged as a safe and effective strategy for treating relapsing infections. With further improvement, the microbial transplantation of feces is likely to become the standard of care for periodic infections. Despite the fact that antibiotic therapy and decontamination in health facilities remain important for infection control, effective probiotics and vaccination are likely to become important tools for preventing infection C. difficile in the future. By this time, C. difficile infection continues to be a common and very painful consequence of the use of antibiotics. Pathogenic C. difficile strains form two protein exotoxins, toxin A and toxin B, which cause damage to the intestinal mucosa and inflammation. The infection can be asymptomatic, cause mild diarrhea or cause severe pseudomembranous colitis. The first step is to stop the use of an antibiotic that causes diarrhea. If diarrhea and colitis are serious or persistent, then the drugs of choice are metronidazole and vancomycin. Clostridium difficile is an anaerobic gram-positive, spore-forming, toxin-producing bacilli that is transmitted to humans through the fecal-oral transmission mechanism. In the United States, C. difficile is the most frequently reported nosocomial pathogen in 2011, with 453,000 cases of C. difficile infection and 29,000 deaths associated with C. Difficile infection. Conclusions. To date, the incidence of C. difficle-infections has increased, due to the wide and often uncontrolled use of antibiotics. It should be noted that antibiotic-associated diarrheas due to C. difficile occupy one of the first places in the structure of morbidity and mortality among infectious diarrheas, representing a serious and antimicrobial problem of therapy in the conditions of the in-patient and among the population. CDI has become an increasingly common infection and has shown an increase in severity over the past few years.http://zmj.zsmu.edu.ua/article/view/141730/141124diarrheaClostridium difficileintestinal mucosadiagnosistreatmentprevention
spellingShingle V. D. Moskaliuk
I. V. Rudan
I. V. Balaniuk
O. V. Myronyk
M. O. Andrushchak
Antibiotic-associated diana, intelligent Clostridium difficiary
Zaporožskij Medicinskij Žurnal
diarrhea
Clostridium difficile
intestinal mucosa
diagnosis
treatment
prevention
title Antibiotic-associated diana, intelligent Clostridium difficiary
title_full Antibiotic-associated diana, intelligent Clostridium difficiary
title_fullStr Antibiotic-associated diana, intelligent Clostridium difficiary
title_full_unstemmed Antibiotic-associated diana, intelligent Clostridium difficiary
title_short Antibiotic-associated diana, intelligent Clostridium difficiary
title_sort antibiotic associated diana intelligent clostridium difficiary
topic diarrhea
Clostridium difficile
intestinal mucosa
diagnosis
treatment
prevention
url http://zmj.zsmu.edu.ua/article/view/141730/141124
work_keys_str_mv AT vdmoskaliuk antibioticassociateddianaintelligentclostridiumdifficiary
AT ivrudan antibioticassociateddianaintelligentclostridiumdifficiary
AT ivbalaniuk antibioticassociateddianaintelligentclostridiumdifficiary
AT ovmyronyk antibioticassociateddianaintelligentclostridiumdifficiary
AT moandrushchak antibioticassociateddianaintelligentclostridiumdifficiary